PATENT CLAIM ANALYSIS

Application Number: 15757728
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "019500"]

Abstract:
Chimeric antigen receptors (CARs) that specifically bind to and immunologically recognize CD276 are disclosed. Related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions relating to the polypeptides and proteins are also disclosed. Methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal are also disclosed.

Claim (Index 6):
The CAR of  claim 1 , wherein the intracellular T cell signaling domain comprises the amino acid sequence of any one or more of SEQ ID NO: 10, 11, 17, and 18.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14779586', '15699419', '14352530', '14384282', '15511973']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884148677042804
- 35 USC 102 Novelty (BERT): 0.5248601678703229
- Combined Prediction Score: 0.7620593977208846
- Mean Citation Score: 316.044788
- Max Citation Score: 337.0633
- Similarity Product: 260.30185357642176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test